COO מחיר חזוי לרווח The Cooper Companies, Inc.
Asset diversification between ophthalmology and women's health protects The Cooper Companies (COO) from market volatility. Effective management ensures double-digit revenue growth through the strategic integration of new divisions. The company's forward P/E NTM demonstrates market expectations, where the 13.40 mark reflects the latest data. Low geopolitical risks and the humanitarian status of its products make the business resilient to trade sanctions.
פילוחי מדדים פיננסיים ומדדי שוק עבור CooperSurgical (COO)
The forward P/E ratio determines the business value relative to expected earnings for the coming year. The current forward P/E of The Cooper Companies (COO), which stands at 13.40, reflects market expectations for capital growth rates. This ratio measures the investment payback period based on future cash flows. For The Cooper Companies, the stability of this metric is supported by low attrition among highly qualified engineers and technologists. Preserving unique intellectual capital minimizes operational risks, justifying the current market valuation.
